HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fred Saad Selected Research

Fatigue

4/2024Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.
12/2023Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer.
1/2022Olaparib tolerability and common adverse-event management in patients with metastatic castration-resistant prostate cancer: Further analyses from the PROfound study.
1/2022Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy.
1/2022Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials.
1/2020Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
1/2019Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer.
9/2018Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidence.
11/2017Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
1/2017Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fred Saad Research Topics

Disease

487Prostatic Neoplasms (Prostate Cancer)
05/2024 - 01/2002
226Neoplasms (Cancer)
04/2024 - 02/2004
140Neoplasm Metastasis (Metastasis)
05/2024 - 01/2002
48Carcinoma (Carcinomatosis)
04/2024 - 10/2002
45Pain (Aches)
12/2023 - 08/2002
40Urinary Bladder Neoplasms (Bladder Cancer)
03/2024 - 02/2005
39Disease Progression
12/2023 - 10/2002
33Renal Cell Carcinoma (Grawitz Tumor)
03/2024 - 11/2005
18Fatigue
04/2024 - 09/2012
15Breast Neoplasms (Breast Cancer)
07/2023 - 01/2002
12Bone Diseases (Bone Disease)
10/2016 - 04/2005
11Lymphatic Metastasis
01/2022 - 02/2004
11Bone Resorption
05/2010 - 10/2002
10Adenocarcinoma
06/2023 - 04/2003
10Margins of Excision
01/2023 - 12/2004
10Multiple Myeloma
04/2022 - 12/2002
9Hypertension (High Blood Pressure)
11/2021 - 05/2011
8Kidney Neoplasms (Kidney Cancer)
03/2024 - 12/2019
8Circulating Neoplastic Cells
12/2019 - 03/2012
7Inflammation (Inflammations)
07/2021 - 05/2009
7Spontaneous Fractures (Pathological Fracture)
09/2012 - 12/2002
6Nausea
04/2024 - 12/2002
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 01/2019
6Osteoporosis
07/2014 - 10/2004
5Bone Fractures (Bone Fracture)
07/2022 - 06/2005
5Cancer Pain
01/2022 - 01/2013
5Urogenital Neoplasms
02/2013 - 11/2005
5Spinal Cord Compression
09/2012 - 06/2005
4Neutropenia
02/2024 - 01/2017
4Non-Muscle Invasive Bladder Neoplasms
01/2022 - 11/2012
4Asthenia
01/2022 - 12/2013
4Prostatic Intraepithelial Neoplasia
11/2021 - 05/2006
4Noninfiltrating Intraductal Carcinoma (DCIS)
11/2021 - 01/2018
4Frailty
09/2021 - 03/2020
4Diarrhea
01/2019 - 09/2012

Drug/Important Bio-Agent (IBA)

126AndrogensIBA
05/2024 - 12/2004
72Prostate-Specific Antigen (Semenogelase)IBA
05/2024 - 08/2004
68Hormones (Hormone)IBA
05/2024 - 01/2002
58Zoledronic Acid (Zometa)FDA Link
03/2024 - 01/2002
47Docetaxel (Taxotere)FDA Link
04/2024 - 08/2008
47enzalutamideIBA
12/2023 - 09/2012
41Diphosphonates (Bisphosphonates)IBA
04/2022 - 01/2002
37Biomarkers (Surrogate Marker)IBA
12/2023 - 12/2007
33abirateroneIBA
04/2024 - 05/2011
29Prednisone (Sone)FDA LinkGeneric
09/2023 - 08/2008
28Androgen Receptors (Androgen Receptor)IBA
04/2024 - 09/2006
26Abiraterone AcetateIBA
09/2023 - 05/2011
24DenosumabFDA Link
03/2024 - 08/2009
18apalutamideIBA
04/2024 - 01/2018
18Radium-223IBA
02/2024 - 09/2013
18Testosterone (Sustanon)FDA Link
12/2023 - 05/2015
16olaparibIBA
04/2024 - 01/2018
14Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2010
13taxaneIBA
02/2024 - 09/2011
11NF-kappa B (NF-kB)IBA
01/2014 - 02/2004
10AntigensIBA
03/2024 - 08/2008
10cabazitaxelFDA Link
10/2018 - 01/2013
8relugolixIBA
12/2023 - 12/2015
8Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2023 - 12/2014
8Indicators and Reagents (Reagents)IBA
01/2022 - 10/2013
8Monoclonal AntibodiesIBA
06/2014 - 08/2009
7darolutamideIBA
04/2024 - 01/2022
7Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2023 - 01/2018
7LigandsIBA
07/2023 - 05/2008
7collagen type I trimeric cross-linked peptideIBA
09/2015 - 01/2005
6Alkaline PhosphataseIBA
03/2024 - 01/2005
6Leuprolide (Lupron)FDA LinkGeneric
12/2023 - 01/2020
6DNA (Deoxyribonucleic Acid)IBA
11/2023 - 09/2013
6Collagen Type I (Type I Collagen)IBA
09/2015 - 12/2007
6RANK LigandIBA
10/2013 - 05/2008
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2024 - 01/2020
5Opiate AlkaloidsIBA
01/2022 - 01/2013
5Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2021 - 03/2012
5OGX-011IBA
11/2017 - 09/2010
4LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
11/2023 - 01/2020
4Antineoplastic Agents (Antineoplastics)IBA
10/2023 - 06/2005
4Dihydrotachysterol (AT 10)IBA
06/2023 - 08/2014
4Hemoglobins (Hemoglobin)IBA
01/2023 - 08/2007
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2023 - 08/2007
4RadiopharmaceuticalsIBA
12/2022 - 02/2013
4Opioid Analgesics (Opioids)IBA
04/2022 - 01/2017
4cabozantinibIBA
03/2022 - 06/2014
4ParaffinIBA
12/2019 - 02/2004

Therapy/Procedure

229Therapeutics
05/2024 - 01/2002
199Castration
04/2024 - 05/2006
103Prostatectomy (Retropubic Prostatectomy)
05/2024 - 04/2003
83Drug Therapy (Chemotherapy)
03/2024 - 01/2002
80Radiotherapy
05/2024 - 06/2005
50Cystectomy
08/2023 - 02/2005
32Nephrectomy
03/2024 - 04/2009
25Lymph Node Excision (Lymph Node Dissection)
04/2024 - 06/2008
20Nephroureterectomy
04/2024 - 04/2012
9Length of Stay
03/2024 - 01/2019
9Immunotherapy
12/2023 - 08/2011
8Orchiectomy (Orchidectomy)
12/2023 - 05/2005
8Aftercare (After-Treatment)
12/2023 - 09/2006
8Brachytherapy
11/2021 - 12/2008
6Palliative Care (Palliative Therapy)
04/2024 - 01/2010
5Continuity of Patient Care
01/2017 - 12/2004
4Adjuvant Radiotherapy
10/2020 - 09/2015